Molecular Rationale behind the Differential Substrate Specificity of Bacterial RND Multi-Drug Transporters by Ramaswamy, Venkata Krishnan et al.
1SCientifiC REPORts | 7: 8075  | DOI:10.1038/s41598-017-08747-8
www.nature.com/scientificreports
Molecular Rationale behind the 
Differential Substrate Specificity 
of Bacterial RND Multi-Drug 
Transporters
Venkata Krishnan Ramaswamy1, Attilio V. Vargiu  1, Giuliano Malloci1, Jürg Dreier2 &  
Paolo Ruggerone  1
Resistance-Nodulation-cell Division (RND) transporters AcrB and AcrD of Escherichia coli expel a 
wide range of substrates out of the cell in conjunction with AcrA and TolC, contributing to the onset 
of bacterial multidrug resistance. Despite sharing an overall sequence identity of ~66% (similarity 
~80%), these RND transporters feature distinct substrate specificity patterns whose underlying basis 
remains elusive. We performed exhaustive comparative analyses of the putative substrate binding 
pockets considering crystal structures, homology models and conformations extracted from multi-
copy μs-long molecular dynamics simulations of both AcrB and AcrD. The impact of physicochemical 
and topographical properties (volume, shape, lipophilicity, electrostatic potential, hydration 
and distribution of multi-functional sites) within the pockets on their substrate specificities was 
quantitatively assessed. Differences in the lipophilic and electrostatic potentials among the pockets 
were identified. In particular, the deep pocket of AcrB showed the largest lipophilicity convincingly 
pointing out its possible role as a lipophilicity-based selectivity filter. Furthermore, we identified 
dynamic features (not inferable from sequence analysis or static structures) such as different flexibilities 
of specific protein loops that could potentially influence the substrate recognition and transport profile. 
Our findings can be valuable for drawing structure (dynamics)-activity relationship to be employed in 
drug design.
Antimicrobial resistance has re-emerged as one of the major challenges to public health worldwide, especially 
due to the spread of multidrug-resistant (MDR) or even pan-resistant Gram-negative pathogenic bacteria1. The 
intrinsic drug resistance shown by these bacteria can be largely attributed to the primary barrier imposed by 
their membranes, endowed with chromosomally encoded molecular filters (porins) and drug efflux pumps2. 
Among these, MDR efflux pumps transport a wide range of structurally dissimilar substrates including antibiotics 
from various classes, posing a major concern in clinical therapy3, 4. In particular, the Resistance-Nodulation-cell 
Division (RND) superfamily members are notoriously known for the extremely wide substrate specificity3, 5–8 
and are considered to be involved in both intrinsic and acquired MDR. The RND pump complexes span the 
entire periplasmic space from the inner membrane (IM) to the outer membrane (OM) by forming tripartite 
systems9–13 comprising an RND transporter protein embedded in the IM, an adaptor protein (a.k.a. membrane 
fusion protein, MFP) located in the periplasmic space, and an outer-membrane protein (OMP) constituting a 
long alpha-helical and beta-barrel tunnel (Fig. 1).
AcrB is the best characterized RND transporter8, and its structure has been solved by several labs both without 
and with bound substrates and inhibitors14–18. Structurally, AcrB is an asymmetric trimer resembling a jellyfish 
with each protomer comprising a total of 3 domains8 (Fig. 1): (i) a trans-membrane domain consisting of 12 
α-helices embedded in the IM, where energy conversion takes place via proton coupling; (ii) a pore (porter) 
domain located in the periplasm, where substrate recruitment and transport occur; and (iii) a periplasmic fun-
nel domain, which connects the RND transporter to the OMP via the assembly of MFPs19 in the constituted 
pump. It has been proposed that substrate transport in these proteins follows a “functional rotation mechanism” 
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(Fig. 2) in which concerted but not necessarily synchronous cycling of the protomers occurs through any of the 
so far identified asymmetric states: Loose (L) (a.k.a. Access) in which substrates bind to a peripheral site named 
access pocket (AP); Tight (T) (a.k.a. Binding) in which substrates bind to a more deep pocket (DP); and Open 
(O) (a.k.a. Extrusion) in which the substrate is released into the central funnel leading towards the OMP14, 20, 21. 
The two pockets (Fig. 2) were previously identified in AcrB as the binding sites responsible for the recognition 
and selectivity of different molecules15, 22–24. Namely, the AP and DP have been hypothesized to be responsi-
ble for the recognition of high-molecular-mass and low-molecular-mass compounds, respectively15. They are 
separated by a G-rich (a.k.a. switch) loop whose flexibility has been shown to be important for the transport of 
high-molecular-mass molecules15, 16.
Figure 1. Structure of the RND tripartite pump AcrAB-TolC. AcrAB-TolC pump is shown here with AcrB as 
the RND component, AcrA as the MFP and TolC as the OMP. In the inset, the general structure of an RND 
transporter is displayed, where the three main domains (TMD, PD, and FD) are indicated.
Figure 2. Proposed functional rotation mechanism of substrate extrusion by RND transporters. (a) Top view 
illustrating the different conformations assumed by AP, DP and Exit Gate (EG) during the three cycles of the 
functional rotation mechanism. The substrate (orange) is represented by van der Waals spheres and its pathway 
along the cycle is indicated by short black arrows. The key regions housing the substrate are coloured dull when 
binding to the substrate, bright otherwise. (b) Front view of the putative substrate transport pathway from AP 
to EG going through DP. The pathway is shown as thick tube, coloured in blue and magenta for the stages of 
the transport cycle associated to the Loose→Tight and Tight→Open conformational changes, respectively. The 
substrate is represented by sticks coloured green, red and iceblue when interacting with the AP, DP and EG (also 
coloured green, red and iceblue), respectively. The G-loop separating AP and DP is shown as a yellow cartoon.
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AcrD is a close homolog of AcrB in Escherichia coli with an overall sequence identity (similarity) of nearly 
66% (80%) (Supplementary Figs S1–S2). These moderate differences however impact on their substrate specificity 
patterns, which overlap only partially (Table 1 and Supplementary Fig. S3). While certain substrates like most of 
the beta-lactam antibiotics are common, macrolides and tetracyclines are transported by AcrB but not by AcrD, 
which instead exports aminoglycosides, in turn not recognized by AcrB. Categorizing the typical substrates of 
the two transporters on the basis of their physicochemical properties (Table 2) highlights that they are essentially 
hydrophobic and hydrophilic for AcrB and AcrD, respectively, while both transporters might shuttle out amphi-
philic compounds.
However, such a simplistic classification is not of help either to improve our basic knowledge on RND trans-
porters or in drug design efforts. Achieving a deeper level of information would be highly desirable, and a first 
step towards this goal consists in mapping the differences in substrate specificities between these two proteins in 
terms of defined structural, chemical and dynamic features of their putative substrate-binding pockets, whose 
link has not been traced yet. From a domain-wise perspective, two previous studies attempted to identify sub-
strate recognition site(s) in these RND pumps by using chimeric analysis22, 25. The importance of periplasmic loop 
regions in RND pumps was pointed out by Elkins and Nikaido25, Mao et al.26, Eda et al.27 and Kobayashi et al.22. 
In particular, Kobayashi et al.22 identified a few residues in the AP as potential determinants of specificity towards 
negatively charged beta-lactams (aztreonam, carbenicillin, and sulbenicillin). Namely, by replacing three residues 
in AcrB with the corresponding ones in AcrD (Q569R, I626R, and E673G), the authors were able to confer to the 
former transporter the ability to recognize anionic beta-lactams, typical substrates of the latter protein.
However, these findings concerning the overall location of the sites responsible for substrate recognition were 
restricted to a subclass of compounds, and no comprehensive molecular-level rationale for the different spe-
cificities of AcrB and AcrD has been proposed yet. This void of knowledge traces back mainly to the lack of 
experimental structures of AcrD and of co-crystal structures of any RND transporter with compounds belonging 
to beta-lactam, fluoroquinolone or aminoglycoside classes. On the other hand, computational modeling, in par-
ticular all-atom MD simulations, have already proven to be insightful in addressing the molecular mechanisms 
of RND transporters8, 28–38. Moreover, given the overall good sequence identity and similarity between AcrB and 
AcrD of E. coli, reliable computational modeling of AcrD and related structure-based studies are possible.
Prompted by this consideration and with the aim to explain in a more deep and informative meaning the sub-
strate specificities of AcrB and AcrD in terms of matching properties with the corresponding (substrate) binders, 
we performed a systematic comparison of the physicochemical nature of the main putative substrate binding sites 
(AP and DP) (Fig. 2) between AcrB and AcrD. Importantly, beside crystal structures or homology models, we 
included for both transporters conformations extracted from extensive multi-copy μs-long molecular dynamics 
(MD) simulations. This robust computational setup allowed us to extend the realm of structure-function relation 
to account for subtle interplay between behavior of solvent, charge distribution, structural changes associated 
with the time-evolution of the system under physiological-like conditions. We characterized and compared the 
molecular properties (pocket descriptors) of the binding pockets such as their flexibility, accessible binding vol-
ume, lipophilic index, electrostatic potential, hydration and multi-functional sites. In particular, we identified 
dynamic features not inferable from simple sequence analysis, such as the positional flexibility of a loop lining the 
base of AP and likely playing a key role in regulating access and transport of substrates in these RND transporters. 
We also pinpointed specific differences in the lipophilic and electrostatic potentials in the binding pockets of 
these transporters, which complement the physicochemical properties of the known substrates of these pumps 
and are present also when dynamics of the pocket is accounted for. In particular, in AcrB an electrostatic funnel 
with negative gradient leading from the periplasm to the centre of the AP shows up in our configurations whilst it 
is absent in AcrD. Additionally, the DP of AcrB features a more lipophilic character, if compared to AcrD, point-
ing out the involvement of this pocket as a lipophilicity-based selectivity filter.
Transporter(s) AcrB AcrD AcrB and AcrD
Antibiotic substrates
Macrolides (erythromycin), 
chloramphenicol, 
Fluoroquinolones 
(ciprofloxacin), Tetracyclines 
(tetracycline, tigecycline, 
minocycline), doxorubicin, 
acriflavine
Aminoglycosides 
(amikacin, 
gentamicin, 
kanamycin, 
neomycin)
Most beta-lactams 
(aztreonam, 
sulbenicillin), 
Aminocoumarins 
(novobiocin)
Table 1. Antibiotic substrate specificities of the paralog RND transporters AcrB and AcrD from E. coli22, 25, 46, 80–84. 
Classes of compounds are indicated, with examples of specific compounds within parentheses (2D chemical 
structures of these compounds are shown in Supplementary Figure S3).
Antibiotic substrate type 
(Physicochemical property)
E. coli
AcrB AcrD
Hydrophobic + −
Hydrophilic − +
Amphiphilic + +
Table 2. General physicochemical properties of antibiotic substrates of AcrB and AcrD.
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The correlation of the different specificity patterns of these two transporters to the dynamic physicochemical 
and topographical properties of their multi-functional recognition sites could be highly informative for drug 
design attempts8.
Results
Sequence Assessment. Bacteria have an inherent ability to change their genetic makeup and adapt them-
selves in response to adverse environmental stress. In order to extend the results of our study to Acr proteins 
extracted from E. coli other than the specific one used here, we determined the presence and distribution of 
conserved regions in AP and DP of all the available AcrB and AcrD sequences in the UniProtKB (October 2016) 
(http://www.uniprot.org/blast/). Shannon entropy39 was computed for both the Acr proteins and expressed in 
terms of H factor. This descriptor is commonly used to quantify sequence conservation considering the prob-
ability of occurrence of an amino acid at each site in a sequence alignment. Multiple sequence alignment and 
Shannon entropy analysis together pointed out an overall high sequence conservation of these proteins in all E. 
coli strains. In particular, all the H factors associated with the Shannon entropy were lower than 1, indicating a 
high degree of conservation.
Molecular dynamics simulations of AcrB and AcrD. MD simulations of AcrB were done using the 
high-resolution asymmetric crystal structure (PDB ID: 4DX516), each protomer being in Loose, Tight, and Open 
conformations, respectively. Since the structure of AcrD has not been experimentally resolved yet, we generated a 
homology model of AcrD based on the same AcrB crystal structure (4DX5) as its template using Modeller 9.1340 
(see Methods section). According to RMSD analyses of the complete trimeric protein backbone and of each 
protomer in relation to the initial structure (Supplementary Fig. S4), we determined the equilibration time of 
~0.5 μs to be most suitable for both AcrB and AcrD. The cluster representatives (see respectively Supplementary 
Figures S5 and S6 for the sampling of AP and DP clusters in AcrB and AcrD along the MD simulations) extracted 
from the equilibrated trajectories of AcrB and AcrD were used to characterize the distribution of accessible 
binding volume, molecular lipophilicity, electrostatic potential and multi-functional sites (MFS). Hydration 
analyses were performed on equilibrium trajectories. Although the level of confidence in homology models can-
not be as high as that in experimental structures, we have thoroughly validated the AcrD structures by using 
state-of-the-art bioinformatic tools (details are reported in Methods and in Supplementary Information, see in 
particular Supplementary Table S1). The stability of the AcrD model as well as its suitability for subsequent analy-
ses were validated in two independent μs-long MD simulations. This multiple validation of the AcrD model offers 
a fairly good confidence in the representativity of the clusters extracted from MD trajectories as configurations 
explored by the system. In the following, we present the results from these analyses on the AP and DP.
Access Pocket of the Loose protomer. The AP is a proximally located pocket close to the periplasm 
in the putative substrate transport pathway of RND pumps (Fig. 2) and also likely the site of recognition for 
high-molecular-mass compounds15. In order to identify if any of the physicochemical properties could be used 
to differentiate between the APs and in addition to determine which substrate could likely be recognized by these 
APs, we calculated the following descriptors on the AP of Loose protomer in both AcrB and AcrD.
Pocket Volume and Shape. The extent and the shape of the three dimensional space that a ligand is allowed to 
explore to find its optimal binding pose in any putative binding pocket is governed by multiple factors, the pri-
mary being the accessible binding volume. Especially with promiscuous proteins like the RND transporters, one 
would expect that a large binding site with a reasonable degree of plasticity will facilitate binding of molecules 
with a wide range of sizes. The pocket volumes (Fig. 3a and c and Supplementary Table S2) of pre-MD structures 
(PDB code 4DX516 for AcrB and the final optimized model for AcrD used as starting configuration for MD 
simulations) and the clusters extracted from MD did not, per se, show any relevant differences. Moreover, both 
the volumes and the minimal projection areas of AP in AcrB and AcrD are much larger than those of the largest 
substrates transported by these pumps41 (Supplementary Table S2). However, principal component analysis per-
formed on the equilibrium MD trajectories revealed a slightly different flexibility of the AP in the two proteins, 
namely the pocket in AcrB showed larger rearrangements in the loop residues 675 to 678 lining the base of AP 
(Fig. 3b) whereas in the case of AcrD (Fig. 3d) this region displayed lower flexibility and so was for the entire AP.
Molecular Lipophilicity Potential (MLP) and Lipophilic Index (LI). The calculation of the LIs of the AP showed 
this pocket to be of higher lipophilic nature in AcrB than in AcrD (Table 3 and Supplementary Fig. S7). This is 
compatible with the (at least partial) hydrophobic character required for AcrB substrates. However, the specific 
chemical environment of the AP is neither entirely hydrophobic nor entirely polar in both the proteins (Fig. 4a,b). 
Interestingly, different conformations of the AP displayed similar values of the LIs, so that the relatively higher 
lipophilicity of AcrB with respect to AcrD turned out to be a robust feature compared to the flexibility of the 
AP (Table 3). According to the MLP calculated for the representatives of the most populated structural clusters, 
regions of relatively high lipophilicity for AcrB were located close to the hydrophobic trap (HP-trap) lined by 
residues F136, F178, F610, F615 and F62817, 29, and in a region at the border with the putative entrance known as 
Vestibule42. In contrast, no predominant spots were recognizable for AcrD (Fig. 4a,b).
Electrostatic Potential. The long range potential due to electrostatic interactions makes them a vital component 
of molecular recognition between molecules. The electrostatic potentials calculated on the molecular surfaces of 
the AP of AcrB and AcrD are shown in Fig. 4c,d. The left and right panels collect the results for the pre-MD struc-
tures and for the most populated cluster of each system, respectively. Concerning the pre-MD structures (Fig. 4c), 
positively charged patches were predominant within the AP of AcrD, while the same region of AcrB featured a 
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more even distribution of positive vs. negative charges. Importantly, the partial closure of the pockets seen in the 
MD simulations of the apo proteins did not influence these main findings (Supplementary Fig. S8).
Hydration Analysis. Characterizing the hydration profiles around the binding pockets of these proteins helps 
to effectively understand the molecular mechanism of interaction of water molecules penetrating the pocket in a 
dynamic manner. The radial distribution function (RDF) profile around the AP residues of AcrB and AcrD were 
rather similar with only a minor difference in the intensity of hydration (Fig. 5a). The first solvation shell was 
observed around 1.9 Å in both the proteins with a slightly reduced probability in AcrB. The spatial distribution 
function (SDF) calculated on the trajectory of the most populated cluster extracted from MD simulations, how-
ever, featured no water density spots near the hydrophobic residues in AP of AcrB but showed a higher number 
of dense regions in AcrD at identical density isovalues (Fig. 5b).
Deep Pocket of the Tight protomer. The DP is a more deeply located cavity within the putative substrate 
transport pathway of RND pumps (Fig. 2), and is likely the recognition site for low-molecular-mass compounds15. 
According to the crystal structures, this pocket exists in a collapsed state in the Loose and Open protomers but 
is wide open in the Tight protomer; therefore, all the analyses concerning this site were performed on the Tight 
protomers of AcrB and AcrD. Based on primary sequence analysis, most of the hydrophobic residues in the DP 
Figure 3. Volume dynamics of AP in the Loose protomer of AcrB and AcrD. (Left Panels) Distribution 
of the volume of AP within the Loose protomer of AcrB (a) and AcrD (c), calculated for the 10 top cluster 
representatives extracted from equilibrium MD trajectories. Histograms refer to the values of the volume, lines 
to the relative population of the corresponding clusters. The volumes calculated for the pre-MD structures of 
AcrB and AcrD are shown as dashed line. (Right Panels) Porcupine plots representing collective motions along 
the first principal-component eigenvector for AP in AcrB (b) and AcrD (d) simulations shown as arrows (>2 Å) 
attached to Cα atoms indicating the magnitude of the corresponding eigenvalues. The loop lining the base of AP 
(‘bottom-loop’) showing large rearrangement in AcrB but not in AcrD are coloured yellow in both.
System
LI
Pre-MD MD clusters
AcrB 7.2 7.0 ± 1.0
AcrD 1.2 1.6 ± 0.6
Table 3. Lipophilic indexes of AP in the Loose protomer of AcrB and AcrD. For AcrB, the pre-MD structure 
corresponds to the crystal structure identified by PDB code 4DX516 while for AcrD it is the final optimized 
homology model used as starting configuration for MD simulations.
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of AcrB are replaced by polar/charged amino acids in AcrD (Supplementary Figs S1–S2). The ensuing effects on 
the physicochemical environment of the DP were thus characterized by the aforementioned pocket descriptors.
Pocket Volume and Shape. As for the AP, also the DP showed a partial closure during dynamics yet displaying 
volumes and minimal projection areas (Fig. 6a and c and Supplementary Table S3) large enough to accommodate 
its ligands. The cluster distribution was similarly slightly more extended for AcrD than for AcrB. The principal 
component analysis data showed the DP in AcrD with essential dynamics spread throughout the pocket unlike 
the less dynamic and more localized motions of DP in AcrB (Fig. 6b and d).
Figure 4. MLP and electrostatic potential of AP in the Loose protomer of AcrB and AcrD. MLP isosurfaces 
observed within 4 Å of AP in the Loose protomer of AcrB (blue) and AcrD (red) in pre-MD (a) and the 
representatives of the most populated cluster (b) as seen from the centre of the protomer. The hydrophobic/
aromatic residues in the AP are shown as sticks in the structures. Isosurfaces at 0.75 (solid), 0.5 (dark 
transparent) and 0.25 (light transparent) are shown in blue (AcrB) or red (AcrD). The HP-trap and 
Vestibule sites are also labeled in the pre-MD structure of AcrB. The electrostatic potential plotted on the 
molecular surface representation of AP in the Acr proteins in the pre-MD (c) and the most populated cluster 
representative (d) as seen from the periplasmic front of the protomer. The colour code is red to blue from 
negative (−10 kbT/e) to positive (+10 kbT/e) potential, where kb is the Boltzmann constant, T is the absolute 
temperature and e is the electron charge.
Figure 5. Hydration of AP in the Loose protomer of AcrB and AcrD. (a) Comparison of RDF profiles of water 
oxygen atoms around AP (all atoms) in the Loose protomer of AcrB (red solid line) and AcrD (brown dash-
dotted line) extracted from the equilibrium MD trajectories. (b) Comparison of SDF of waters within the AP 
of Loose protomer. The SDF was calculated over the configurations forming the most populated cluster of AcrB 
(left) and AcrD (right). The isosurfaces are shown at density isovalue of 6, meaning that the represented surfaces 
correspond to 6 times higher average number density of solvent molecules than bulk (see Subsection Hydration 
in Methods). The AP and DP are marked in green and red while the G-loop in yellow cartoon representations. 
The hydrophobic/aromatic residues of the pocket are shown as cyan sticks in the respective structures.
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MLP and LI. The DP featured larger differences than the AP in the values of the LIs calculated for AcrB and 
AcrD, despite a reduction in the absolute values when considering the weighted average value extracted from the 
MD clusters compared to pre-MD structures (Table 4). The LI values indicated a much more prominent hydro-
phobic character of this pocket in AcrB than AcrD. Most clusters of AcrB were associated with LI values larger 
than 10, the highest values occurring for clusters 1, 3, 5, and 8 (LI of 14.4, 17.1, 17.0, and 17.2 respectively; see 
Supplementary Fig. S9). Together, the first three clusters embraced 80% of the conformations sampled by AcrB. 
In AcrD, the most populated clusters (1 to 5) had LIs ranging from 0.5 to 2.8 (Supplementary Fig. S9). Therefore, 
as already seen for the AP, the MLP proved to be a robust feature of the pockets, conserved across different con-
formations assumed in the dynamics. The lipophilic potential surfaces of the pre-MD and the most populated 
clusters are reported in Fig. 7a,b highlighting the presence of pronounced lipophilic regions in AcrB in compari-
son to three less extended spots in AcrD.
Electrostatic Potential. The electrostatic potential projected on the surfaces of the DP indicated a relatively 
denser positive environment in AcrD than in AcrB (blue areas in Fig. 7c,d). Noticeable is that the difference was 
better emphasized when the electrostatic potential surfaces were compared for the representatives of the most 
populated clusters. In AcrB, an extended surface area of negative potential appeared while in AcrD the distri-
bution of areas of negative and positive potentials did not change much and the latter still presented a greater 
positive component with dispersed negative components. As in the case of AP, the partial closure of the pockets 
seen in the MD simulations of the apo proteins did not influence these main findings (Supplementary Fig. S10).
Hydration Analysis. The RDF profile of water around the DP showed a minor difference in the intensity of the 
peak between AcrB and AcrD, essentially related to the different hydration of the HP-trap region17 (Fig. 8a). This 
is also consistent with the replacement of three out of the five phenylalanine residues in AcrD that are present in 
Figure 6. Volume dynamics of DP in the Tight protomer of AcrB and AcrD. (Left Panels) Volume distribution 
of DP in the Tight protomer of AcrB (a) and AcrD (c) over the simulation timescale. (Right Panels) Porcupine 
plots of the first principal-component eigenvector for DP in AcrB (b) and AcrD (d) simulations shown as 
arrows (>2 Å) attached to Cα atoms indicating the magnitude of the corresponding eigenvalues.
System
LI
Pre-MD MD clusters
AcrB 16.3 13.1 ± 3.3
AcrD 4.9 1.9 ± 1.0
Table 4. Lipophilic indexes of DP in the Tight protomer of AcrB and AcrD. See Table 3 for further details.
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Figure 7. MLP and electrostatic potential of DP in the Tight protomer of AcrB and AcrD. See Fig. 4 for further 
details.
Figure 8. Hydration of DP and HP-trap in the Tight protomer of AcrB and AcrD. (a) Comparison of RDF 
profiles of water oxygen atoms around the DP (all atoms) and HP-trap (all atoms) in the Tight protomer of AcrB 
(red solid line) and the corresponding regions of AcrD (brown dash-dotted line). (b) Comparison of SDF for 
waters in the DP calculated over the configurations forming the most populated cluster of AcrB (left) and AcrD 
(right) illustrating the variation in the immediate environment of the hydrophobic residues. The position of the 
HP-trap in DP of AcrB is indicated by an arrow. See Fig. 5 for further details.
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the HP-trap of AcrB (only F610 and F628 are conserved). Indeed, the SDF clearly displayed a very low probability 
of hydration near this region in AcrB (Fig. 8b).
Fragment-Based Binding Site Characterization. In addition to global physicochemical pocket descrip-
tors discussed above, the ligand-binding properties of protein are governed by the number, strength and spatial 
distribution of binding energy hot spots43. A fragment-based binding site analysis was thus performed employing 
probes (Supplementary Fig. S11) of different physicochemical features to identify hotspots responsible for speci-
ficity by mapping the chemical functionalities on the internal surface of the two proteins.
Several multi-functional sites (MFSs) were identified within the binding pockets of AcrB and AcrD. While the 
AP of both proteins showed consistently higher number of MFSs in comparison to the DP (Table 5), the level of 
promiscuity became distinct on comparing the MFSs in the latter pocket. The DP in AcrB showed an extended 
MFS (Fig. 9) in the pre-MD structure where substrates like minocycline14–16, doxorubicin14, 16 and inhibitors like 
P9D17 and MBX293144 were crystallographically resolved. Although closure of the DP during the simulations 
resulted in the loss of the large extended MFS found in pre-MD, it created other MFS thereby preserving the 
promiscuity of DP in AcrB as seen in the representatives of the most populated clusters (Fig. 9 and Supplementary 
Fig. S12). In AcrD, the DP and interface/G-loop showed only a few consensus sites (CSs) and lacked a true MFS in 
both the pre-MD as well as the clusters sampled during MD. An interesting feature was that the interface between 
the pockets including the G-loop almost always favored an MFS in AcrB.
Discussion
AcrB and AcrD are the major RND transporters of E. coli. They feature an overall good level of sequence (and 
likely fold) identity and similarity, and indeed show partly overlapping substrate specificities. However, they have 
distinct abilities to expel some classes of compounds; for instance, only AcrD recognizes aminoglycosides. The 
peculiarities of each transporter are likely related to the specific physicochemical features of the main recognition 
pockets, i.e. the AP and DP. Indeed, these two sites feature a lower degree of sequence conservation compared 
to the entire protein (see Supplementary Figures S1–S2). In particular, the AP is better conserved than the DP 
with nearly 60% vs. 40% identical residues, respectively. An inspection of the mismatched residues between AcrB 
and AcrD showed that the binding pockets of the latter protein are populated with more polar/charged residues 
than those of the former, likely facilitating the recognition and transport of more hydrophilic molecules by AcrD. 
However, this hypothesis should undergo a validation through the rationalization of the different substrate sus-
ceptibilities in terms of molecular descriptors of the binding pockets. Moreover, the impact of the dynamic nature 
of these transporters on the pocket environment should also be considered for gaining a more realistic under-
standing of their differential recognition and transport events as seen in vitro or in vivo.
For this reason, in this work we compared several molecular descriptors calculated on the two main putative 
binding sites (AP in the Loose protomer and DP in the Tight protomer) within the periplasmic domains of AcrB 
and AcrD. In addition to experimental structures and homology models, which represent static snapshots of these 
biologically dynamic systems, we performed our analyses on a set of structures extracted from extensive MD 
simulations of the apo-proteins for assessing the influence of pocket dynamics. We recall that the MD simulations 
of AcrD were started from a homology model built using the AcrB structure as template. Clearly, the structures 
of cluster representatives for the former protein could feature a lower level of confidence than those of the latter. 
However, the AcrD model was found to be as good as experimental structures using state-of-the-art bioinfor-
matic validation protocols (see Methods). In addition, the MD simulations of AcrD were as stable as those of 
AcrB, further pointing to the reliability of our findings.
The first descriptor we considered was the pocket volume and shape. However, a pure steric filter for substrates 
is quite unlikely because of the large volumes of all the pockets considered in the present analysis, which are at 
Structure
Number of MFSs Total 
number 
of MFSsAP DP
Interface/
G-loop
AcrB
Pre-MD 3 2 2 7
Cluster 1 3 1 1 5
Cluster 2 2 1 1 4
Cluster 3 1 2 1 4
Cluster 4 2 1 1 4
Cluster 5 2 1 1 4
Average 2.2 1.3 1.2 5
AcrD
Pre-MD 1 - 1 2
Cluster 1 1 1 1 3
Cluster 2 3 - - 3
Cluster 3 3 - 1 4
Cluster 4 3 - - 3
Cluster 5 3 1 - 4
Average 2.3 0.3 0.5 3
Table 5. The number of MFSs identified in the binding pockets of AcrB and AcrD before and during MD. See 
Table 3 for further details.
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least twice as voluminous as the largest compounds transported by AcrB and AcrD. Moreover, the average val-
ues of the volumes and minimal projection areas for the AP and the DP of both proteins are, within errors, very 
similar; therefore, differences in the substrate specificities of AcrB and AcrD cannot be traced back to the size of 
such large pockets. Interestingly, in both transporters the two pockets partly collapsed during the MD simulations 
with respect to the conformation seen in the X-ray crystal structures and in the homology models of AcrB and 
AcrD, respectively. The reduction amounted to 30% in both AP and DP of AcrB while it was 15% in the AP and 
28% in the DP of AcrD with respect to the pre-MD structures. This behavior is consistent with the findings of 
Fischer and Kandt33, who noticed a closure of the DP in the Tight protomer of AcrB in the absence of substrate 
during shorter MD simulations than those reported here. In coherence with this hypothesis, we also found the 
DP volume to be at least 1000 Å3 larger in substrate bound complexes (Supplementary Table S4). Moreover, pop-
ulation distributions over the clusters extracted from the MD simulations offer interesting insights into the dif-
ferent behavior of the two transporters. First, for both AP and DP, the first three clusters identified for AcrB cover 
roughly 90% and 80% of the trajectories whilst the distribution is wider for AcrD, especially when AP is con-
sidered. Straightforwardly attributing this diversity to dissimilar flexibility might not be completely correct and 
could hide interesting features associated with the dynamics of the considered regions. For instance, as visualized 
from the porcupine plots of the first principal component (Fig. 3b and d), the entire AP of AcrD exhibits almost a 
coherent motion with similar magnitude of eigenvector (depicted by length of the arrows) whereas in the case of 
AcrB, the loop residues 675 to 678 lining the base of AP show larger rearrangements. The dynamicity of this loop 
(Thr676-loop or hereafter referred to as ‘bottom-loop’) represents a peculiar feature in the AP of AcrB, which is 
unshared with AcrD. The structures of the cluster representatives of AcrB can be partitioned in two groups fea-
turing “up” and “down” conformation of the bottom-loop (Fig. 10). The most populated cluster is characterized 
by an “up” conformation, while the crystal structures exhibited only “down” configuration, as for the second most 
populated cluster representative (Supplementary Fig. S13). A similar flip is not observed in AP of AcrD, and 
the analogous of the bottom-loop is always close to the pre-MD arrangement. With such major conformational 
shifts of the bottom-loop in AcrB, it is very likely that this loop contributes towards induced fit and minimizes 
the steric hindrance for the large substrates of AcrB, a hypothesis that is compatible with the larger size of some 
AcrB substrates that are not transported by AcrD. The importance of this bottom-loop in regulating access to 
porter domain and its possible active role in substrate transport by pushing compounds towards the hydrophobic 
binding pocket was already suggested by Fischer and Kandt, who however sampled only “down” conformations in 
their MD simulations33. Moreover, according to Kobayashi and co-workers the mutation E673G (located close to 
Figure 9. MFSs identified in the AP and DP of AcrB and AcrD. MFSs in the AP and DP of pre-MD (left panels) 
and the most populated cluster representative (right panel) structures of AcrB and AcrD. The binding modes 
of the different probes are shown as lines for hydrogen-bond donor (cyan), hydrogen-bond acceptor (violet) 
and aliphatic (yellow), and as CPK for aromatic (ochre) ligands. The AP and DP are marked in green and 
red, respectively, while the G-loop in yellow cartoon representations. (Note: The categorizing of MFSs here is 
arbitrary due to indistinct boundaries between the pockets. The sites not labelled as MFS here are all CSs).
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the bottom-loop) in AcrB, in combination with Q569R and I626R, conferred this protein the ability to recognize 
anionic beta-lactams, which are typical substrates of AcrD. Thus, the analysis of the volumes, although not much 
enlightening per se, allowed identifying specific structural features more directly involved in the entrance into 
and transport to a pocket, which might be of relevance in determining substrate specificity.
Next to the volume analysis, we calculated the LIs for the AP and the DP of both transporters in order to quan-
tify how different distribution of hydrophobic residues could affect substrate recognition and how this property 
is tuned by the dynamics of the protein. Both pockets of AcrB are consistently characterized by higher LI values 
than those of AcrD, independently of the somewhat important structural changes occurring in these pockets 
during the MD simulations of the apo-proteins (Tables 3 and 4). The higher lipophilic nature of AP and DP in 
AcrB when compared to that of the same pockets in AcrD is required for AcrB to provide a favorable environment 
for its hydrophobic substrates to bind. However, the specific chemical environment of the AP is neither entirely 
hydrophobic nor entirely polar in both the proteins. Such a dispersed nature binds ligands with different physico-
chemical properties by weak polar and hydrophobic interactions45, while facilitating easy transport by preventing 
strong interactions of the substrates with residues of the pocket. Note that the values of the LIs for AP and DP of 
AcrD are essentially identical whilst in AcrB there is a marked difference between the two sites, the DP being the 
more lipophilic. This could be an indication of DP being the site where substrates might be differentiated between 
AcrB and AcrD in terms of their lipophilicity. In other words, the DP could function as a lipophilicity-based 
selectivity filter for low-molecular-mass compounds. This proposal agrees with previous suggestions based on 
experimental results of Yamaguchi et al.46. The difference between the DP of AcrB and AcrD became even more 
prominent by comparing their molecular lipophilic surfaces (Fig. 7a,b). The MLP isosurfaces are significantly 
wider in AcrB than in AcrD, which correlates well with the nature of the reported substrates transported by the 
former protein. Interestingly, the presence of phenylalanines in the G-loop of only AcrB creates a large hydro-
phobic bridge between the DP and the AP, which would facilitate anchoring of aromatic compounds from the AP 
and their subsequent transport to the DP. The presence of polar/charged residues in the DP of AcrD results in its 
increased hydration when compared to the DP of AcrB, and the nature of water dynamics in this region would 
further influence the binding behavior of potential substrate molecules.
The local stereochemistry and distribution of functional groups in a region govern both the ordering of water 
molecules and their biologically important interactions in that region. The structure and the dynamics of the 
first water hydration shells around a putative binding pocket is of primary importance, given the relevance of 
water displacement for the free energy balance of the recognition event47. The plot of the SDF around the AP and 
the DP of both transporters highlight how their different hydrophobic potentials influence hydration profiles. 
In particular, a lower degree of hydration was seen near the hydrophobic part of the AP in AcrB than in AcrD 
(Fig. 5b). Even for the DP, our analysis provides a clear evidence of the contribution of the HP-trap in determining 
the lower hydration of the domain compared to AcrD. While several spots are homogeneously distributed in the 
SDF calculated for AcrD, the DP featured several zones without hydration in AcrB, especially around the HP-trap 
(Fig. 8b).
Electrostatic complementarity between the pocket and substrate molecules is essential for initial substrate 
recruitment and augmentation of their association rate48. Therefore, this analysis is of particular interest for the 
AP, which is more peripheral than the DP. For AcrB, the distribution of positively and negatively charged patches 
on the molecular surface of this site is fairly homogeneous (Fig. 4c,d). Interestingly, in AcrB an electrostatic fun-
nel with negative gradient leading from the periplasm to the centre of the AP is recognizable in Fig. 11, which 
could help the long-range recognition of positively charged compounds, and is compatible with the monocationic 
character of several substrates of AcrB. The electrostatic surface of this site in AcrD reveals instead a marked 
positive patch on the upper part, also due to the presence of residues like Arg568 and Arg625, which have been 
recently reported as key residues for specificity of AcrD towards negatively charged molecules like the anionic 
beta-lactams22.
Figure 10. Main conformational states of the Thr676-loop (bottom-loop) in the Loose protomer of AcrB (left 
panel) and of the corresponding Ser675-loop in AcrD (right panel). The conformation of the most populated 
clusters and the pre-MD structures are shown in red and grey cartoons, respectively. The conformations of the 
G-loop are also indicated with the same colour code.
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Concerning the DP, the large electrostatic negative environment presented to the incoming substrate in AcrB 
would favor the recognition and binding of cationic compounds. However, this becomes unfavorable to hydro-
philic polycationic aminoglycosides due to the high lipophilicity of this pocket in AcrB functioning as a prob-
able lipophilicity-based selectivity filter as discussed above. In AcrD, a relatively denser positive environment 
compared to AcrB is identifiable, originating from the electrostatic contributions of amino acids like Arg and 
Lys replacing their less polar counterparts in AcrB (Supplementary Figs S1–S2). In conjunction with the low 
lipophilicity of this pocket in AcrD, the observed mosaic-like electrostatic patches provide a favorable binding site 
for anionic beta-lactams as well as for polycationic aminoglycosides. On the other side, the poor electrostatic and 
hydrophilic complementarity provided by the DP in AcrB permits the binding of charged molecules like anionic 
beta-lactams but with far less affinity than that in AcrD.
Multidrug transporters are known to have large, flexible overlapping substrate binding pockets rich in polar 
and aromatic residues to bind substrate molecules at different locations with different orientations. In alternate 
terms, these proteins show polyspecificity with no inherent ligand specificity which otherwise could stem from 
the binding site geometry49. Our results suggest that features such as shape, lipophilicity, electrostatic potential 
and hydration of AP and DP are a few distinctive features between AcrB and AcrD. This is in agreement with the 
findings on other multidrug transporters where nonpolar and aromatic side chains impose specific prerequisites 
on drug size and shape. To further establish this, we performed a fragment based binding site characterization 
using FTMap, whose philosophy retraces experimental high-throughput and fragment screening methods. Also, 
as its algorithm does not rely on alternate measures of ligand-binding propensity such as pocket volume, cavity 
depth or the ability of binding non-polar spheres, the results obtained here can complement those from physico-
chemical pocket descriptors discussed above.
As evident from the overall distribution of MFSs (Table 5), both AcrB and AcrD provide multiple binding 
possibilities with different functionalities as expected from such promiscuous transporter proteins. This is dis-
tinct from the limited number of MFSs one would detect in restrained substrate binding sites of other ordinary 
substrate-receptor systems restricted to a specific class of substrates45. In particular, AcrB with its numerous 
and wide spread MFSs offers a greater level of promiscuity for diverse substrate types than AcrD, which with its 
smaller localized MFSs puts forth certain prerequisites on the substrates being recognized. While the AP in both 
proteins showed comparable numbers of MFSs dispersed within the pocket, a clear distinction is noticeable in 
the DP (as also observed with the pocket descriptors discussed above) where a true and wide spread MFS is seen 
only in AcrB. The DP of this transporter is clearly a multi-functional (or multidrug binding) site with higher pref-
erence towards hydrophobic and aromatic fragments alongside hydrogen-bond donor and acceptor fragments. 
The non-selective characteristics of weakly polar (by Q176, G616) and weakly hydrophobic (by F178, Y327, F615, 
F617, F628) interactions are a predominant player towards the promiscuous binding behavior of AcrB DP30. 
The DP of AcrD does not reach the level of multi-functionality seen in AcrB, and shows greater preference for 
hydrogen-bond donors/acceptors (by R44, D134, N136, T139, Y178, Y327, S614, G615), together with a very 
limited preference towards hydrophobic (by Y178, Y277, F627) fragments. The MFSs identified here are in good 
agreement with the data reported for AcrB by Imai et al.45, and were also found close to the residues identified as 
crucial for the recognition of anionic beta-lactams by Kobayashi et al.22, thereby strengthening the reliability of 
our findings.
As seen from the distribution of MFSs in the various MD clusters (Supplementary Fig. S12), their posi-
tion is not constant and this dynamicity (attributed by spatial changes in internal cavities caused by peristaltic 
motions50) is most likely important to avoid the substrate from being trapped in a single site and to facilitate its 
efflux by multisite-drug-oscillation46. Additional studies involving substrate bound complexes can provide infor-
mation on the interaction profile of these homologous Acr pumps with their corresponding substrates. However, 
redundancy in the residue type in the binding pocket leading to easy adaptability of the binding orientation of 
Figure 11. Electrostatic funnel converging into AP in the Loose protomer of AcrB. Only the strongest field 
lines are shown and coloured red to blue from negative (−10 kbT/e) to positive (+10 kbT/e) potential (‘kb’ is the 
Boltzmann constant, ‘T’ is absolute temperature and ‘e’ is charge of an electron). AP is shown in green and the 
rest of the porter domain in white surface representation.
www.nature.com/scientificreports/
13SCientifiC REPORts | 7: 8075  | DOI:10.1038/s41598-017-08747-8
substrates in the presence of mutations as identified by Bohnert et al. in AcrB51 makes these pumps very challeng-
ing for studies with simple molecular docking30.
Conclusions and Perspectives
In this study, we performed a comparative analysis of the physicochemical properties like pocket volume and 
shape, lipophilicity, electrostatic potential, hydration and multi-functional sites of AcrB and AcrD to rationalize 
their differential substrate specificities. Importantly, these analyses were performed not only on static structures 
but also on conformations extracted from extensive MD simulations accounting for the impact of protein dynam-
ics. Our results reveal several features in which both the AP and the DP differ considerably between these two 
transporters. First, the calculated lipophilic potential turned out to be significantly different between the AP and 
DP of AcrB and between the corresponding pockets of AcrB and AcrD considering even the dynamics of the 
pockets. In particular, the DP of AcrB is more lipophilic than all other sites, suggesting the possible role of this 
pocket as a lipophilicity-based selectivity filter. Second, we observed specific differences in the electrostatic envi-
ronment within the pockets. In particular, the presence of an electrostatic funnel sourcing from the AP of AcrB 
could be important for the recognition of monocationic compounds by this transporter. Thus, these two proper-
ties likely play a central role in governing substrate recognition by and specificity of AcrB and AcrD. Meanwhile, 
the cavity volume, which essentially remains large enough to accommodate all potential substrate molecules, 
possibly has an indirect effect on the lipophilic and electrostatic environment along with the distribution of MFS, 
which altogether with the ensuing hydration within the pocket govern recognition and transport of substrates by 
these pumps. In addition, specific features like the flip conformations of the bottom-loop and the lipophilic bridge 
created by Phe617 of G-loop both in AcrB (and not in AcrD), which could not have been identified from simple 
sequence analysis, are expected to play a key role in the recognition and transport function of these pumps.
More exhaustive studies including molecular docking and molecular dynamics simulations of selected sub-
strates in the binding pockets of AcrB and AcrD are being considered to provide substantial information to fur-
ther characterize these putative binding sites on the basis of substrate-protein interaction pattern.
Methods
Homology modeling of AcrD. A reliable structure of the system of interest is the starting and main ingredi-
ent of any structure-based computational study. Since the structure of AcrD has not yet been resolved experimen-
tally, we built it by template-based homology modeling. The amino acid sequence of full length AcrD transporter 
protein from E. coli was retrieved from the UniProt database52 (UNIPROT ID: P24177), and subsequently 
searched for the best available template structures bearing homologous relationship to the query sequence using 
the NCBI-BLAST tool53 against the Protein Data Bank (PDB) (www.rcsb.org). AcrB sequence showed the high-
est identity (~66%) (similarity of ~80%) with least gaps over a maximum sequence coverage; therefore its high 
resolution crystal structure, 1.9 Å (PDB ID: 4DX516), was chosen as template for modeling AcrD. The two protein 
sequences were optimally aligned by ClustalOmega54 and the results were visually inspected to ensure the absence 
of gaps in important secondary structure regions. Modeller 9.1340 was used to generate a total of 100 asymmetric 
models of AcrD based on AcrB template using an optimization method combining slow MD with very thorough 
variable target function method through 300 iterations, and this whole cycle was repeated twice unless the objec-
tive function MOLPDF was greater than 106. The resulting models were ranked using discrete optimized protein 
energy (DOPE)55 score values, and the top 5 models (with the lowest DOPE score) were selected for individual 
structure quality checks. Each model was further subjected to loop refinement using Modeller, and to overall 
structure relaxation by energy minimizations using AMBER1456. The most reliable model was then selected based 
on various geometric and stereochemical quality factors evaluated for backbone angles, side chains flips, rotam-
ers, steric clashes etc. using PROCHECK57, ERRAT58, ProSA59, Verify3D60 programs available in MolProbity61 
and Structure Analysis and Verification Server (http://services.mbi.ucla.edu/SAVES/).
We also performed comparative structural studies by superimposition of the modeled AcrD structure over 
the experimentally determined X-ray crystal structure of AcrB used as the template. All the above methods were 
also employed on the crystal structure of AcrB for use as reference. Visual inspections were performed with 
VMD1.9.162 and PyMOL63.
Molecular dynamics simulations of AcrB and AcrD. MD simulations of the crystal structure of AcrB 
(PDB ID: 4DX5) and of the most reliable homology model of AcrD (see Supplementary Table S1) were carried 
out using the AMBER14 molecular modeling software56. Protomer specific protonation states18 were adopted 
with E346 (E346) and D924 (D922) protonated in both Loose and Tight protomers while deprotonated in the 
Open protomer of AcrB (AcrD). The residues D407 (D407), D408 (D408), D566 were protonated only in the 
Open protomer of AcrB (AcrD). The charge state of the residue L565 of AcrD, corresponding to D566 in AcrB, 
was not modified of course. The topology and the initial coordinate files for these apo-protein structures were 
created using the LEaP module of AmberTools14. The proteins were successively embedded in 1-palmitoyl-2
-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) bilayer patches, solvated with explicit TIP3P water model, 
and neutralized with the required number of randomly placed K+ ions28, 29, 64. The ions count was suitably adjusted 
to account for an osmolarity of 0.15 M KCl. Embedding of the protein into a pre-equilibrated POPE bilayer patch 
was performed using the PPM server65 and subsequently the CharmmGUI tool66. The lipid residue nomenclature 
was converted from the CHARMM to AMBER format using the charmmlipid2amber.py python script provided 
with AmberTools. The central pore lipids were then added after calculating the number of lipids to be added to 
each leaflet by dividing the approximate area of the central pore by the standard area per lipid of POPE mole-
cules67. Periodic boundary conditions were used and the distance between the protein and the edge of the box was 
set to be at least 30 Å in each direction.
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Multi-step energy minimization with a combination of steepest descent and conjugate gradient methods was 
carried out using the pmemd program implemented in AMBER14 to relax internal constrains of the systems by 
gradually releasing positional restraints. Following this, the systems were heated from 0 to 310 K by a 1 ns heat-
ing (0–100 K) under constant volume (NVT) followed by 5 ns of constant pressure heating (NPT) (100–310 K) 
with the phosphorous heads of lipids restrained along the z-axis to allow membrane merging and to bring the 
atmospheric pressure of the system to 1 bar. Langevin thermostat (collision frequency of 1 ps−1) was used to 
maintain a constant temperature, and multiple short equilibration steps of 500 ps under anisotropic pressure 
scaling (Berendsen barostat) in NPT conditions were performed to equilibrate the box dimensions. A time step 
of 2 fs was used during all these runs, while post-equilibrium MD simulations were carried out with a time step 
of 4 fs under constant volume conditions after hydrogen mass repartitioning68. The particle-mesh Ewald (PME) 
algorithm was used to evaluate long-range electrostatic forces with a non-bonded cutoff of 9 Å. During the MD 
simulations, the length of all R–H bonds was constrained with SHAKE algorithm. Coordinates were saved every 
100 ps. The ff14SB69 version of the all-atom Amber force field was used to represent the protein systems while 
lipid1467 parameters were used for the POPE bilayer. After equilibration, multi-copy µs-long MD simulations 
were performed for each system, namely two ~3 μs-long production simulations for each transporter (for a total 
simulation time of ~12 μs). Trajectory analysis was done using cpptraj module of AmberTools14 and VMD1.9.1, 
and graphs were plotted using the xmgrace tool.
Principal component analysis. To characterize and highlight possible similarities and differences in the 
collective motions of the binding pockets, we calculated the covariance matrices from the equilibrium trajectory 
and performed a principal component analysis70, 71. As customary in principal component analysis, the covari-
ance matrix was constructed taking the three-dimensional positional fluctuations of Cα atoms from their ensem-
ble average position (after least-squares fitting to remove rotational and translational motion). Diagonalization of 
the covariance matrix yields a set of eigenvectors and corresponding eigenvalues, which represent the direction 
and amplitude of the motion, respectively. The eigenvectors are then ranked according to the decreasing order 
of their associated eigenvalues, such that the first eigenvector represents the largest contribution to the total 
fluctuation of the system. To visualize the motions represented by the eigenvectors, the structures from the trajec-
tories can be projected onto each eigenvector of interest [principal component (PC)] and transformed back into 
Cartesian coordinates. The two extreme projections along each eigenvector can then be interpolated to create an 
animation or compared to understand which parts of the protein are moving according to that specific eigenvec-
tor and to what extent. Usually, (a combination of) the first few principal components are able to represent most 
of the collective motions (the “essential dynamics”70) occurring in an MD simulation among the different regions 
of a protein.
Clustering of MD trajectories. A cluster analysis of the MD trajectories was performed using the 
average-linkage hierarchical agglomerative clustering method implemented in cpptraj module of AMBER. Such 
clustering helps to reduce the number of structures for analysis yet retaining the large conformational space sam-
pled during the MD runs. In this approach, we clustered in two separate instances the trajectory based on root 
mean square deviation (RMSD) (cutoff set to 3 Å) of the AP in the Loose protomer and of the DP in the Tight pro-
tomer. For each protein, the representative structures from each of the 10 top clusters generated in each of the two 
cases considered (AP in Loose, DP in Tight) were used to perform quantitative analyses in order to account for 
dynamical behavior. Except for hydration analyses, all non-protein molecules were stripped from the trajectory 
during post-processing to reduce additional memory usage and to speed up file processing.
Pocket descriptors. The list of the pocket descriptors identified for the present study includes: i) cav-
ity volume and shape; ii) molecular lipophilicity potential; iii) electrostatic potential; iv) site hydration; v) 
fragment-based binding site characterization. The various pocket descriptors used to characterize the binding 
site were calculated using specific programs after validating their applicability to RND systems by assessing results 
against available crystal structures and experimental data, as well as previous computational reports29, 30, 33, 35, 45, 64.
Cavity volume and shape. Evolution of size and shape of the AP and DP during the MD simulations was exam-
ined using the two-probe sphere method of rbcavity program bundled in the rDock suite72. This allows obtaining 
detailed information on the pocket volume and plasticity of the site. In this method, the binding site volume was 
identified by a fast grid-based cavity detection algorithm73 within a sphere of radius 14 Å, centred over the pock-
ets, using large and small probe radii of 6.0 Å and 1.5 Å, respectively. These radii were found to be optimal for our 
case after evaluating different combinations and checking through visual inspection their accuracy in predicting 
volume of the pocket space by keeping the possible inclusion of regions extending outside the pocket of interest at 
its least. rDock also gives information about the approximate shape of the pocket; we could thus provide approx-
imate values for the minimal cross-sectional area associated to each cavity.
Molecular lipophilicity potential. The three-dimensional distribution of lipophilicity in space or on a molecular 
surface can be described using Molecular Lipophilicity Potential (MLP), which represents the influence of all 
lipophilic fragmental contributions of a molecule on its environment. The MLP value of a point in space (k) is 
generated as the result of intermolecular interactions between all fragments in the molecule and the solvent sys-
tem, at that given point. Thus, MLP can be calculated from the fragmental system of logP and a distance function 
as shown in the following equation74:
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where N is the number of fragments, Fi is the lipophilic contribution of fragment i of the molecule and f(dik) is a 
function based on the distance of the measured point in space k to fragment i.
In this way, summing up all positive and all negative MLP values associated to each point on the binding 
pocket yields the lipophilic index (LI) as:
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The lipophilicity of AP in the Loose protomer and DP in the Tight protomer were qualitatively and quantita-
tively estimated in this way using MLP Tools75 plugin available for PyMOL.
Electrostatic potential. The electrostatic potential surface maps were computed by APBS76, after preprocessing 
structures of AcrB and AcrD to assign charges and atomic radii using the PDB2PQR server77. All electrostatic 
potential calculations were performed at 0.15 M physiological salt concentration, with a solvent probe of radius 
1.4 Å, a solvent dielectric constant of 78.5, a biomolecular dielectric constant of 2.0, a temperature of 310 K, a 
minimum grid spacing of 0.5 Å and keeping the other Poisson-Boltzmann parameters at default.
Hydration analysis. The radial distribution function (RDF) indicates the probability of finding water molecules 
at a certain distance from a region or residue of interest and is commonly used to analyse the solution structure 
revealed from either experimental or computer simulations data.
The RDF analysis of water oxygen atoms was performed using cpptraj module of AMBER14, in which the RDF 
is computed from the histogram of the number of solvent particles found as a function of the distance R from 
an (ensemble of) atom(s), normalized by the expected number of solvent particles at that distance in bulk. The 
normalization is estimated from:
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where dR is equal to the bin spacing, the default density value is 0.033456 molecules Å−3, which corresponds to 
density of water approximately equal to 1.0 g mL−1. Bin spacing of 0.1 and a maximum bin value of 4.0 was used 
in this case to calculate the RDF of all water oxygen atoms to each atom of AP in the Loose protomer and of DP in 
the Tight protomer over the entire length of the simulation.
Though RDF clearly shows a difference in the water distribution around the desired regions, it lacks the ability 
to present the information about the spatial positions of these differences. Hence, spatial distribution function 
(SDF) of waters around the whole protein was calculated using the Gromacs utility g_spatial78 on the trajectory 
frames grouped into the most populated conformational clusters extracted from MD simulations. SDF allows 
to determine the three-dimensional density distribution of aqueous solution around the binding pockets of the 
transporters. Density isovalue gives information regarding the relative number densities with respect to the aver-
age number density of solvent molecules in bulk. RDF and SDF together highlight the hydration around the 
binding pockets of these proteins, which can be effectively used to understand the molecular mechanism of inter-
action of water molecules penetrating the pocket in a dynamic manner.
Fragment-Based Binding Site Characterization. The FTMap server79 implementing the FTSite algorithm is a tool 
helpful in the identification of binding sites and of the fragments that could be possible source of structure- and 
fragment-based drug design attempts. The main aim of such fragment-based binding site analysis is to obtain a 
measure of the ability of the protein (and in particular the pockets under study) to bind a drug-like molecule.
FTMap identifies the important hot spots based on the consensus clusters of 16 standard probes which include 
molecules varying in size, shape and polarity (Supplementary Fig. S11). Such a diverse library of probes is useful 
to capture a range of interaction types that include hydrophilic, hydrophobic, hydrogen-bonding and aromatic 
interactions. The regions where clusters of different probes of the same or different type overlap are marked as 
consensus (CS) and multi-functional (MFS) sites, respectively, and are ranked based on the number of their 
clusters. Clusters in close proximity to a top ranked cluster are merged with it and the protein residues within this 
region become the top ranked putative ligand binding site.
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